Holen Sie sich die Stockscreener-App
0.70
0.43%
0.003
Handel nachbörslich:
.67
-0.03
-4.29%
Calcimedica Inc Aktie (CALC) Neueste Nachrichten
Aug Highlights: What’s the fair value of DUK.PRA stockQuarterly Trade Review & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Earnings Risk: Does CalciMedica Inc meet Warren Buffetts criteria2025 Price Momentum & Technical Pattern Recognition Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
How Is The Market Feeling About CalciMedica Inc? - Benzinga
What is CalciMedica Inc.’s book value per shareWeekly Trend Summary & AI Enhanced Trading Signals - mfd.ru
CalciMedica downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
This CalciMedica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga
CalciMedica Shares Plunge After Discontinuing Phase II AKI Study - Citeline News & Insights
CalciMedica stock downgraded to Neutral by H.C. Wainwright after trial halt - Investing.com Canada
CalciMedica’s stock drops 75% on acute kidney injury trial termination - Clinical Trials Arena
CalciMedica discontinues AKI trial following safety concerns By Investing.com - Investing.com South Africa
CALC Stock Slumped 76% On Wednesday — Here’s Why - Stocktwits
CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation By Investing.com - Investing.com Nigeria
CalciMedica Discontinues Trial, Stock Faces Volatility - intellectia.ai
CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation - Investing.com
Calcimedica Discontinues Phase 2 Kourage Trial - TradingView
CalciMedica Ends KOURAGE Trial, Extends Cash Runway - TipRanks
Sector Update: Health Care - marketscreener.com
CalciMedica oversold on KOURAGE news, says Oppenheimer - TipRanks
CalciMedica ( CALC) Stock: Stops Phase 2 KOURAGE trial amid Enrollment Criteria Concerns - parameter.io
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Gold Jumps Over 4%; Seagate Shares Gain After Q2 Results - Benzinga
Calcimedica sags on halt of Auxora trial in acute kidney injury - BioWorld MedTech
CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis - Benzinga
CalciMedica Shares Hit 52-Week Low After Ending Auxora Trial - marketscreener.com
Nasdaq Gains 150 Points; Starbucks Shares Rise After Strong Sales - Benzinga
CalciMedica stock craters as trial stopped over 'safety concern' - Fierce Biotech
CalciMedica tumbles as safety concerns halt trial of kidney injury drug - TradingView
CalciMedica stock plunges after discontinuing kidney injury trial By Investing.com - Investing.com Australia
CalciMedica stock plunges after discontinuing kidney injury trial - Investing.com
CalciMedica Halts Phase 2 KOURAGE Trial After Safety Review - TipRanks
CalciMedica discontinues AKI trial following safety concerns - Investing.com
CalciMedica announces discontinuation of Phase 2 KOURAGE clinical trial - TipRanks
CalciMedica Inc Discontinues Phase 2 KOURAGE Trial - TradingView
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation - PR Newswire
Does CalciMedica Inc have consistent dividend growthSell Signal & Real-Time Market Sentiment Reports - baoquankhu1.vn
Aug Catalysts: Why is Neurocrine Biosciences Inc stock going upPortfolio Update Report & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Why CalciMedica Is A Stock To Watch - Nasdaq
Will CalciMedica Inc benefit from rising consumer demandEarnings Summary Report & Fast Moving Market Watchlists - baoquankhu1.vn
CalciMedica (NASDAQ:CALC) Upgraded to Sell at Wall Street Zen - Defense World
One new option listing on January 13th - TipRanks
Is MOTMQ stock a good choice for value investorsJuly 2025 PostEarnings & Free High Accuracy Swing Entry Alerts - ulpravda.ru
Will EDAG Engineering Group AG (ED4) stock recover faster than industryNew Guidance & Daily Oversold Stock Bounce Ideas - Улправда
Is CalciMedica Inc. stock a top momentum playJuly 2025 Momentum & Capital Protection Trade Alerts - Улправда
How CalciMedica Inc. stock reacts to job market data2025 Market WrapUp & Precise Swing Trade Alerts - Улправда
How CalciMedica Inc. stock reacts to global recession fearsJobs Report & Free Long-Term Investment Growth Plans - Улправда
2026 world cup usa national team qualification veteran players low block defense betting odds explained2025 AllTime Highs & AI Powered Market Entry Strategies - Улправда
Will Progress Software Corporation stock benefit from infrastructure spendingMarket Risk Summary & Growth Focused Entry Reports - ulpravda.ru
Investors Hope for Bounce in Meyer Apparel Limited After Selloff2025 Performance Recap & Stepwise Trade Signal Implementation - Улправда
Is Kennametal Inc. stock resilient to inflationQuarterly Portfolio Review & AI Driven Stock Price Forecasts - Улправда
Kamdhenu Ventures Limited (543747) Quarterly Results Are OutDividend Reinvestment Plans & Free Discover Dynamic Stocks - bollywoodhelpline.com
Aug Movers: How CalciMedica Inc stock reacts to job market dataPortfolio Performance Summary & High Accuracy Investment Entry Signals - Bộ Nội Vụ
CalciMedica (NASDAQ:CALC) Trading Down 2.1%Time to Sell? - MarketBeat
CalciMedica (NASDAQ:CALC) Trading Down 2.1% – Time to Sell? - Defense World
Can CalciMedica Inc. stock rebound after recent weaknessInstitutional Buying Trends & Use Time as Your Investing Ally - bollywoodhelpline.com
1.24%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):